Bausch & Lomb (BLCO) Income from Continuing Operations (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Income from Continuing Operations came in at 10000000.0 in Q2 2026, up 82.76% YoY from 5471698.11 in Q2 2025, and up 85.71% on a QoQ basis from 70000000.0 in Q1 2026.
Bausch & Lomb (BLCO) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Income from Continuing Operations data on file, last reported at 10000000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 82.76% year-over-year to 10000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 163000000.0 (up 38.02% YoY) and the FY2025 annual result came in at 352000000.0, down 15.41% from the prior year.
- Income from Continuing Operations climbed to 10000000.0 in Q2 2026, from 70000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 23000000.0 in Q1 2022 to a low of 211000000.0 in Q1 2025.
- A 5-year average of 57058823.53 and a median of 51000000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 110.0% — and 2025, when it plunged 2800.0%.
- Tracing BLCO's Income from Continuing Operations over 5 years: stood at 15000000.0 in 2022, then slumped by 240.0% to 51000000.0 in 2023, then surged by 96.08% to 2000000.0 in 2024, then sank by 2800.0% to 58000000.0 in 2025, then surged by 82.76% to 10000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 10000000.0 (Q2 2026), 70000000.0 (Q1 2026), and 58000000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.00 Mn |
| Mar 31, 2026 | -70.00 Mn |
| Dec 31, 2025 | -58.00 Mn |
| Sep 30, 2025 | -25.00 Mn |
| Jun 30, 2025 | -58.00 Mn |
| Mar 31, 2025 | -211.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -148.00 Mn |
| Mar 31, 2024 | -163.00 Mn |
| Dec 31, 2023 | -51.00 Mn |
| Sep 30, 2023 | -80.00 Mn |
| Jun 30, 2023 | -29.00 Mn |
| Mar 31, 2023 | -88.00 Mn |
| Sep 30, 2022 | -15.00 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 23.00 Mn |
| Dec 31, 2021 | 54.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 46.00 Mn |